Literature DB >> 6218560

In vitro activity of moxalactam against anaerobic bacteria.

M J Gilchrist, J A Washington.   

Abstract

Moxalactam was tested against 80 isolates of anaerobic bacteria from clinical specimens. The results of this study and a review of other studies, in which comparable susceptibility testing methods were used, demonstrated the susceptibility to moxalactam of members of the Bacteroides fragilis group, Bacteroides melaninogenicus, Fusobacterium species, anaerobic gram-positive cocci, and Clostridium perfringens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218560     DOI: 10.1093/clinids/4.supplement_3.s511

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  4 in total

1.  Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.

Authors:  V L Sutter; J Emmerman; E Randall; R J Zabransky; R J Birk
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

2.  Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.

Authors:  E J Bow; T J Louie
Journal:  CMAJ       Date:  1987-09-01       Impact factor: 8.262

Review 3.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 4.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.